Related Experiment Video
Updated: Jul 18, 2025

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated
Jing Ye1, Yuting Wu1, Yao Chen2
1Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang `University, Hangzhou, Zhejiang, China.
Abstract:
Hypopharyngeal squamous cell carcinoma (HPSCC) is one of the most aggressive cancers and is notorious for its extremely poor prognosis. However, very few molecular biological studies have been performed. As a novel method of epigenetic gene modulation, N6-methyladenosine (m6A) RNA modification occurs in HPSCC. The expression of the m6A demethylase AlkB homolog 5 (ALKBH5) is frequently downregulated in human HPSCC. Furthermore, we found that ALKBH5 impaired cell proliferation by regulating human Toll-like receptor 2 (TLR2) in an m6A-dependent manner in HPSCC cells. ALKBH5 decreased TLR2 m6A modification, which could be recognized by the m6A readers IGF2BP2 and YTHDF1. IGF2BP2 facilitates TLR2 mRNA stability, whereas YTHDF1 promotes TLR2 mRNA translation. The current work uncovered a critical function of ALKBH5 in TLR2 regulation and provides a novel role for m6A demethylation of mRNA in HPSCC. The inhibition of m6A modification of ALKBH5 in HPSCC deserves further clinical investigation.
Insights
AlkB homolog 5 (ALKBH5) is downregulated in hypopharyngeal squamous cell carcinoma (HPSCC), impairing cell proliferation. ALKBH5 regulates Toll-like receptor 2 (TLR2) via N6-methyladenosine (m6A) modification, offering a new therapeutic target for HPSCC.
Area of Science:
- Molecular Oncology
- Epigenetics
- Cancer Biology
Background:
- Hypopharyngeal squamous cell carcinoma (HPSCC) is highly aggressive with a poor prognosis.
- Limited molecular studies exist for HPSCC.
- N6-methyladenosine (m6A) RNA modification is a novel epigenetic mechanism with potential roles in HPSCC.
Purpose of the Study:
- Investigate the role of the m6A demethylase AlkB homolog 5 (ALKBH5) in HPSCC.
- Elucidate the mechanism by which ALKBH5 affects HPSCC cell proliferation.
- Identify downstream targets regulated by ALKBH5 in HPSCC.
Main Methods:
- Analysis of ALKBH5 expression in HPSCC tissues.
- Investigation of ALKBH5's effect on HPSCC cell proliferation.
- Assessment of Toll-like receptor 2 (TLR2) regulation by ALKBH5 in an m6A-dependent manner.
- Identification of m6A readers (IGF2BP2, YTHDF1) involved in TLR2 regulation.
Main Results:
- ALKBH5 expression is frequently downregulated in human HPSCC.
- ALKBH5 impairs HPSCC cell proliferation.
- ALKBH5 decreases TLR2 m6A modification, impacting its stability and translation via IGF2BP2 and YTHDF1.
- This reveals a novel regulatory pathway involving ALKBH5, m6A modification, and TLR2 in HPSCC.
Conclusions:
- ALKBH5 plays a critical role in regulating TLR2 in HPSCC through m6A demethylation.
- The ALKBH5-TLR2 axis represents a novel mechanism in HPSCC pathogenesis.
- Targeting ALKBH5 or m6A modification warrants further clinical investigation for HPSCC treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Apoptosis
Abnormal Proliferation